Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
European Archives of Oto-Rhino-Laryngology
Erschienen in: European Archives of Oto-Rhino-Laryngology 6/2013

01.05.2013 | Review Article

The role of positron emission tomography and positron emission tomography/computed tomography in thyroid tumours: an overview

verfasst von: Giorgio Treglia, Barbara Muoio, Luca Giovanella, Massimo Salvatori

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

Positron emission tomography (PET) and PET/computed tomography (PET/CT) with different tracers have been increasingly used in patients with thyroid tumours. The aim of this article is to perform an overview based on literature data about the usefulness of PET imaging in this setting. The role of Fluorine-18-Fluorodeoxyglucose (FDG) PET and PET/CT in differentiated thyroid carcinoma (DTC) is well established, particularly in patients presenting with elevated serum thyroglobulin levels and negative radioiodine whole-body scan. Iodine-124 PET and PET/CT may serve a role in staging DTC and obtaining lesional dosimetry for a better and more rationale planning of treatment with Iodine-131. FDG-PET and PET/CT are useful in the post-thyroidectomy staging of high-risk patients with less differentiated histological subtypes. PET and PET/CT with different tracers seem to be useful methods in localizing the source of elevated calcitonin levels in patients with recurrent medullary thyroid carcinoma. Incorporation of FDG-PET or PET/CT into the initial workup of patients with indeterminate thyroid nodules at fine needle aspiration biopsy deserves further investigation. FDG-PET report should suggest further evaluation when focal thyroid incidentalomas are described because these findings are associated with a significant risk of cancer.
Literatur
1.
Treglia G, Cason E, Fagioli G (2010) Recent applications of nuclear medicine in diagnostics (first part). Ital J Med 4:84–91CrossRef
2.
Abraham T, Schöder H (2011) Thyroid cancer–indications and opportunities for positron emission tomography/computed tomography imaging. Semin Nucl Med 41:121–138PubMedCrossRef
3.
Giovanella L (2012) Positron emission tomography/computed tomography in patients treated for differentiated thyroid carcinomas. Expert Rev Endocrinol Metab 7:35–43CrossRef
4.
Feine U, Lietzenmayer R, Hanke JP, Wöhrle H, Müller-Schauenburg W (1995) 18FDG whole-body PET in differentiated thyroid carcinoma. Flipflop in uptake patterns of 18FDG and 131I. Nuklearmedizin 34:127–134PubMed
5.
American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214PubMedCrossRef
6.
Dong MJ, Liu ZF, Zhao K et al (2009) Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: a meta-analysis. Nucl Med Commun 30:639–650PubMedCrossRef
7.
Ma C, Xie J, Lou Y, Gao Y, Zuo S, Wang X (2010) The role of TSH for 18F-FDG-PET in the diagnosis of recurrence and metastases of differentiated thyroid carcinoma with elevated thyroglobulin and negative scan: a meta-analysis. Eur J Endocrinol 163:177–183PubMedCrossRef
8.
Giovanella L, Ceriani L, De Palma D, Suriano S, Castellani M, Verburg FA (2012) Relationship between serum thyroglobulin and 18FDG-PET/CT in 131I-negative differentiated thyroid carcinomas. Head Neck 34:626–631PubMedCrossRef
9.
Robbins RJ, Wan Q, Grewal RK et al (2006) Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-d-glucose-positron emission tomography scanning. J Clin Endocrinol Metab 91:498–505PubMedCrossRef
10.
Freudenberg LS, Jentzen W, Stahl A, Bockisch A, Rosenbaum-Krumme SJ (2011) Clinical applications of 124I-PET/CT in patients with differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 38(Suppl 1):S48–S56PubMedCrossRef
11.
Freudenberg LS, Antoch G, Frilling A et al (2008) Combined metabolic and morphologic imaging in thyroid carcinoma patients with elevated serum thyroglobulin and negative cervical ultrasonography: role of 124I-PET/CT and FDG-PET. Eur J Nucl Med Mol Imaging 35:950–957PubMedCrossRef
12.
Grabellus F, Nagarajah J, Bockisch A, Schmid KW, Sheu SY (2012) Glucose transporter 1 expression, tumor proliferation, and iodine/glucose uptake in thyroid cancer with emphasis on poorly differentiated thyroid carcinoma. Clin Nucl Med 37:121–127PubMedCrossRef
13.
Pryma DA, Schöder H, Gönen M, Robbins RJ, Larson SM, Yeung HW (2006) Diagnostic accuracy and prognostic value of 18F-FDG PET in Hürthle cell thyroid cancer patients. J Nucl Med 47:1260–1266PubMed
14.
Poisson T, Deandreis D, Leboulleux S et al (2010) 18F-fluorodeoxyglucose positron emission tomography and computed tomography in anaplastic thyroid cancer. Eur J Nucl Med Mol Imaging 37:2277–2285PubMedCrossRef
15.
American Thyroid Association Guidelines Task Force, Kloos RT, Eng C, Evans DB et al (2009) Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 19:565–612PubMedCrossRef
16.
Treglia G, Rufini V, Salvatori M, Giordano A, Giovanella L (2012) PET imaging in recurrent medullary thyroid carcinoma. Int J Mol Imaging 2012:324686PubMed
17.
Rufini V, Treglia G, Perotti G, Leccisotti L, Calcagni ML, Rubello D (2008) Role of PET in medullary thyroid carcinoma. Minerva Endocrinol 33:67–73PubMed
18.
Treglia G, Villani MF, Giordano A, Rufini V (2012) Detection rate of recurrent medullary thyroid carcinoma using fluorine-18 fluorodeoxyglucose positron emission tomography: a meta-analysis. Endocrine. doi:10.​1007/​s12020-012-9671-6
19.
Treglia G, Cocciolillo F, Di Nardo F et al (2012) Detection rate of recurrent medullary thyroid carcinoma using fluorine-18 dihydroxyphenylalanine positron emission tomography: a meta-analysis. Acad Radiol 19:1290–1299PubMedCrossRef
20.
Treglia G, Castaldi P, Villani MF et al (2012) Comparison of 18F-DOPA, 18F-FDG and 68 Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma. Eur J Nucl Med Mol Imaging 39:569–580PubMedCrossRef
21.
Conry BG, Papathanasiou ND, Prakash V et al (2010) Comparison of (68)Ga-DOTATATE and (18)F-fluorodeoxyglucose PET/CT in the detection of recurrent medullary thyroid carcinoma. Eur J Nucl Med Mol Imaging 37:49–57PubMedCrossRef
22.
Naswa N, Sharma P, Suman S et al (2012) Prospective evaluation of 68 Ga-DOTA-NOC PET-CT in patients with recurrent medullary thyroid carcinoma: comparison with 18F-FDG PET-CT. Nucl Med Commun 33:766–774PubMedCrossRef
23.
Treglia G, Rindi G, Rufini V (2012) Expression of somatostatin receptors may guide the use of somatostatin receptor imaging and therapy in differentiated thyroid cancer. Hormones 11:230–232
24.
Treglia G, Castaldi P, Villani MF et al (2012) Comparison of different positron emission tomography tracers in patients with recurrent medullary thyroid carcinoma: our experience and a review of the literature. Recent Results Cancer Res 194:385–393CrossRef
25.
Vriens D, de Wilt JH, van der Wilt GJ, Netea-Maier RT, Oyen WJ, de Geus-Oei LF (2011) The role of [(18) F]-2-fluoro-2-deoxy-d-glucose-positron emission tomography in thyroid nodules with indeterminate fine-needle aspiration biopsy: systematic review and meta-analysis of the literature. Cancer 117:4582–4594PubMedCrossRef
26.
Deandreis D, Al Ghuzlan A, Auperin A et al (2012) Is (18)f-fluorodeoxyglucose-PET/CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology? Thyroid 22:165–172PubMedCrossRef
27.
Giovanella L, Suriano S, Maffioli M, Ceriani L (2011) 18FDG-positron emission tomography/computed tomography (PET/CT) scanning in thyroid nodules with nondiagnostic cytology. Clin Endocrinol 74:644–648CrossRef
28.
Jin J, McHenry CR (2012) Thyroid incidentaloma. Best Pract Res Clin Endocrinol Metab 26:83–96PubMedCrossRef
29.
Iyer NG, Shaha AR, Silver CE et al (2010) Thyroid incidentalomas: to treat or not to treat. Eur Arch Otorhinolaryngol 267:1019–1026PubMedCrossRef
30.
31.
Rothman IN, Middleton L, Stack BC Jr, Bartel T, Riggs AT, Bodenner DL (2011) Incidence of diffuse FDG uptake in the thyroid of patients with hypothyroidism. Eur Arch Otorhinolaryngol 268:1501–1504PubMedCrossRef
32.
Soelberg KK, Bonnema SJ, Brix TH, Hegedüs L (2012) Risk of malignancy in thyroid incidentalomas detected by (18)f-fluorodeoxyglucose positron emission tomography: a systematic review. Thyroid 22:918–925PubMedCrossRef
33.
Bertagna F, Treglia G, Piccardo A, Giubbini R (2012) Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas. J Clin Endocrinol Metab. doi:10.​1210/​jc.​2012-2390
34.
Treglia G, Giovanella L, Bertagna F, Di Franco D, Salvatori M (2012) A pooled analysis to calculate the prevalence and risk of malignancy of thyroid incidentalomas detected by Fluorine-18-Fluorodeoxyglucose positron emission tomography. Thyroid. doi:10.​1089/​thy.​2012-0216
Metadaten
Titel
The role of positron emission tomography and positron emission tomography/computed tomography in thyroid tumours: an overview
verfasst von
Giorgio Treglia
Barbara Muoio
Luca Giovanella
Massimo Salvatori
Publikationsdatum
01.05.2013
Verlag
Springer-Verlag
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 6/2013
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-012-2205-2

Weitere Artikel der Ausgabe 6/2013

European Archives of Oto-Rhino-Laryngology 6/2013 Zur Ausgabe

Head and Neck

Survival and failure outcomes in locally advanced esthesioneuroblastoma: a single centre experience of 15 patients

Rhinology

Interleukin-17A contributes to the expression of serum amyloid A in chronic rhinosinusitis with nasal polyps

Head and Neck

Validation of contrast-enhanced ultrasound-derived intensity–time gradients in submandibular gland sialolithotomy patients

Head and Neck

Free flaps in orbital exenteration: a safe and effective method for reconstruction

Otology

Tinnitus in patients with profound hearing loss and the effect of cochlear implantation

Head and Neck

Supracricoid laryngectomy with cricohyoidoepiglottopexy (CHEP) in the management of laryngeal carcinoma: oncologic results. A 35-year experience

Neu im Fachgebiet HNO

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Eingreifen von Umstehenden rettet vor Erstickungstod

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Real-World-Daten sprechen eher für Dupilumab als für Op.

14.05.2024 Rhinosinusitis Nachrichten

Zur Behandlung schwerer Formen der chronischen Rhinosinusitis mit Nasenpolypen (CRSwNP) stehen seit Kurzem verschiedene Behandlungsmethoden zur Verfügung, darunter Biologika, wie Dupilumab, und die endoskopische Sinuschirurgie (ESS). Beim Vergleich der beiden Therapieoptionen war Dupilumab leicht im Vorteil.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen
Bildnachweise